300 related articles for article (PubMed ID: 17103173)
1. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
[TBL] [Abstract][Full Text] [Related]
2. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.
Duzova A; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bassoy Y; Yilmaz E
Clin Exp Rheumatol; 2003; 21(4):509-14. PubMed ID: 12942707
[TBL] [Abstract][Full Text] [Related]
3. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.
Çakan M; Aktay Ayaz N; Keskindemirci G; Karadağ ŞG; Tanatar A; Sönmez HE
Clin Rheumatol; 2020 Jan; 39(1):249-253. PubMed ID: 31485845
[TBL] [Abstract][Full Text] [Related]
4. Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients.
Stankovic Stojanovic K; Hentgen V; Fellahi S; Georgin-Lavialle S; Amselem S; Grateau G; Bastard JP; Steichen O
Clin Biochem; 2017 Mar; 50(4-5):206-209. PubMed ID: 27838405
[TBL] [Abstract][Full Text] [Related]
5. The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.
Çakan M; Karadağ ŞG; Tanatar A; Sönmez HE; Ayaz NA
J Clin Rheumatol; 2021 Jan; 27(1):1-4. PubMed ID: 31524848
[TBL] [Abstract][Full Text] [Related]
6. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review.
Erer B; Demirkaya E; Ozen S; Kallinich T
Rheumatol Int; 2016 Apr; 36(4):483-7. PubMed ID: 26712372
[TBL] [Abstract][Full Text] [Related]
7. The Relationship Among the Level of Serum Amyloid A, High-Density Lipoprotein and Microalbuminuria in Patients With Familial Mediterranean Fever.
Uslu AU; Aydin B; Icagasıoğlu IS; Balta S; Deveci K; Alkan F; Yıldız G; Sahin A
J Clin Lab Anal; 2016 Nov; 30(6):1003-1008. PubMed ID: 27094695
[TBL] [Abstract][Full Text] [Related]
8. A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever.
Berkun Y; Padeh S; Reichman B; Zaks N; Rabinovich E; Lidar M; Shainberg B; Livneh A
Semin Arthritis Rheum; 2007 Dec; 37(3):182-8. PubMed ID: 17512038
[TBL] [Abstract][Full Text] [Related]
9. S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever.
Taylan A; Gurler O; Toprak B; Sisman AR; Yalcin H; Colak A; Sari I
J Korean Med Sci; 2015 Sep; 30(9):1241-5. PubMed ID: 26339162
[TBL] [Abstract][Full Text] [Related]
10. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
[TBL] [Abstract][Full Text] [Related]
11. The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.
Bozaci I; Tatar E
Int Urol Nephrol; 2021 Mar; 53(3):531-538. PubMed ID: 33058037
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
[TBL] [Abstract][Full Text] [Related]
13. Is Familial Mediterranean Fever a thrombotic disease or not?
Demirel A; Celkan T; Kasapcopur O; Bilgen H; Ozkan A; Apak H; Arisoy N; Yildiz I
Eur J Pediatr; 2008 Mar; 167(3):279-85. PubMed ID: 17436016
[TBL] [Abstract][Full Text] [Related]
14. [Serum amyloid a protein concentrations in patients with familial Mediterranean fever].
Dzhndoian ZT
Georgian Med News; 2011 Dec; (201):48-51. PubMed ID: 22306501
[TBL] [Abstract][Full Text] [Related]
15. [Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M; Loiselet J; Lefranc G; Mégarbané A
Sante; 2004; 14(4):261-6. PubMed ID: 15745878
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic validity of colchicine in patients with Familial Mediterranean fever.
Ozaltin F; Bilginer Y; Gülhan B; Bajin I; Erdogan O; Hayran M; Yılmaz E; Ozen S
Clin Rheumatol; 2014 Jul; 33(7):969-74. PubMed ID: 24740462
[TBL] [Abstract][Full Text] [Related]
17. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever.
Kisacik B; Akdogan A; Yilmaz G; Karadag O; Yilmaz FM; Koklu S; Yuksel O; Ertenli AI; Kiraz S
Eur J Intern Med; 2009 Jan; 20(1):44-7. PubMed ID: 19237091
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever.
Yildirim K; Uzkeser H; Keles M; Karatay S; Kiziltunc A; Kaya MD; Yildirim A
Biochem Med (Zagreb); 2012; 22(1):109-13. PubMed ID: 22384525
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis.
Bilginer Y; Ozaltin F; Basaran C; Duzova A; Besbas N; Topaloglu R; Ozen S; Bakkaloglu A
Rheumatol Int; 2008 Oct; 28(12):1211-6. PubMed ID: 18500463
[TBL] [Abstract][Full Text] [Related]
20. Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis?
Deveci K; Korkmaz S; Senel S; Deveci H; Sancakdar E; Uslu AU; Deniz A; Alkan F; Seker MM; Sencan M
Ren Fail; 2014 Apr; 36(3):339-44. PubMed ID: 24320110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
